Here, we inform the studies of HLA-E presentation in HIV-1 infection by identification of 4 definite and 5 candidate novel HIV-1-derived minimal peptides capable of binding to HLA-E*01:03 and discuss these results in the context of HLA-E-targeted vaccine and immunotherapeutic modalities. Here, HLA-E is linked to HIV-1 infection.